The FDA has approved several GLP-1 receptor agonists for type 2 diabetes management and, in some cases, chronic weight management
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, while tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist
However, dont be discouraged if results are slower than expected, as GLP-1 Medication works gradually to promote sustainable weight loss
Eden offers a comprehensive package that includes ongoing support and regular check-ins to optimize your treatment
Other forms of Semaglutide GLP-1 and tirzepatide are approved for use in medical weight management as well
Response to letter regarding article, Heart failure, saxagliptin and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial